Status:
UNKNOWN
Phenotyping of the Out-of-proportion Pulmonary Hypertension
Lead Sponsor:
Assiut University
Conditions:
1- Haemodynamic Phenotyping of the Out - of - Proportion PH to Guide Different Therapeutic Lines
Eligibility:
All Genders
18-70 years
Brief Summary
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases. The complexi...
Eligibility Criteria
Inclusion
- All Patients presented with severe pulmonary hypertension (PASP \> 70mmHg by echocardiographic assessment) (8) associated with chronic lung diseas will be included in the study
Exclusion
- 1- Age under 18 years. 2- Severe PH proportional to the disease. 3- Hemodynamically unstable condition requiring inotropic or vasoactive drugs. 4- Severe chest wall deformity. 5- Pregnant women. 6- Right-sided endocarditis, right-sided tumor, or thrombus. 7- Severe coagulopathy or bleeding diathesis
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06051396
Start Date
December 1 2023
End Date
December 1 2025
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud Badwy
Asyut, Egypt